Department of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Department of Respiration, Peking University Third Hospital, Beijing, China.
Surg Endosc. 2022 Jun;36(6):4408-4416. doi: 10.1007/s00464-021-08791-6. Epub 2022 Jan 10.
Neuroendocrine tumors (NETs) are a group of heterogenous tumors originating from neuroendocrine system. Approximately, 40 percent will go through liver metastases, and liver-directed therapy was proved to improve the survival outcome. Parenchyma-sparing hepatectomy is advocated for the resection of NETs liver metastases while the possible relatively low negative margin rate is concerned. Indocyanine green (ICG) fluorescence imaging provides a real-time navigation on determination of surgical margins in colorectal cancer liver metastases. However, there was no previous study that reported the applications of ICG fluorescence imaging in NETs liver metastases. The present study aimed to evaluate the feasibility and security of using ICG fluorescence imaging to determine surgical margins of NETs liver metastases during operation.
A retrospective two-arm cohort study was performed on 25 consecutive patients with NETs liver metastases who underwent laparoscopic parenchyma-sparing hepatectomy (LPSH). Patients were divided into two groups according to whether or not the ICG fluorescence imaging was used. Data on sociodemographic characteristics, laboratory parameters, pathology results, and surgical outcomes were collected.
A total of 145 tumors pathologically diagnosed with NETs liver metastases were resected from 25 patients. The pathological results indicated negative margins in all tumors (102/102) in LPSH with ICG fluorescence imaging group. The negative margin rate was significantly higher in LPSH using the ICG fluorescence imaging (100% v.s 88.4%, p = 0.002). Surgical outcomes, including operation time, estimated blood loss, intraoperative transfusion rate, and postoperative morbidity, were comparable between LPSH with and without ICG fluorescence imaging groups.
ICG fluorescence imaging showed the potential to identify tumor boundaries and determine surgical margins. This technique may serve as a valuable intraoperative navigation in patients with NETs liver metastases.
神经内分泌肿瘤(NETs)是一组起源于神经内分泌系统的异质性肿瘤。大约 40%的 NETs 会发生肝转移,而针对肝脏的治疗方法已被证实可以改善患者的生存结局。为了切除 NETs 肝转移病灶,主张采用保肝的肝切除术,但该术式的切缘阴性率可能相对较低。吲哚菁绿(ICG)荧光成像为结直肠癌肝转移提供了实时导航以确定手术切缘。然而,目前尚无研究报道 ICG 荧光成像在 NETs 肝转移中的应用。本研究旨在评估在 NETs 肝转移手术中使用 ICG 荧光成像确定手术切缘的可行性和安全性。
回顾性分析了 25 例连续接受腹腔镜保肝肝切除术(LPSH)的 NETs 肝转移患者的资料。根据是否使用 ICG 荧光成像将患者分为两组。收集患者的社会人口学特征、实验室参数、病理结果和手术结果等数据。
共从 25 例患者中切除了 145 个经病理诊断为 NETs 肝转移的肿瘤。在使用 ICG 荧光成像的 LPSH 组中,所有肿瘤(102/102)的切缘均为阴性,切缘阴性率显著高于未使用 ICG 荧光成像的 LPSH 组(100%比 88.4%,p=0.002)。使用 ICG 荧光成像与未使用 ICG 荧光成像的 LPSH 组之间的手术结果,包括手术时间、估计出血量、术中输血率和术后发病率,均无显著差异。
ICG 荧光成像显示了识别肿瘤边界和确定手术切缘的潜力。该技术可能成为 NETs 肝转移患者的一种有价值的术中导航工具。